BBL
BIIB icon

Beck Bode LLC’s Biogen BIIB Stock Holding History

Beck Bode LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,677
Closed -$2.76M – 117
2023
Q4 		$2.76M Buy
+10,677
New +$2.62M 0.62% 52
2021
Q3 		– Sell
-100
Closed -$35K – 106
2021
Q2 		$35K Buy
+100
New +$30.3K 0.01% 154
2020
Q4 		– Sell
-100
Closed -$28K – 36
2020
Q3 		$28K Buy
+100
New +$27.9K 0.01% 144

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beck Bode LLC's BIIB Position: Q1 2024 in Review

Beck Bode LLC sold out of Biogen (BIIB) in Q1 2024, closing a stake of 10,677 shares — an estimated $2.76M sold.

Beck Bode LLC first reported a position in BIIB in Q3 2020 and held it in 3 quarters. The position peaked at $2.76M in Q4 2023. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Beck Bode LLC reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Beck Bode LLC sold 10,677 Biogen shares in Q1 2024, an estimated $2.76M.
  • Beck Bode LLC first reported a position in Biogen in Q3 2020 and held it in 3 quarters.
  • Beck Bode LLC's Biogen position peaked at $2.76M in Q4 2023.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Beck Bode LLC's 13F filing for Q1 2024, filed 22 May 2024.